Results 151 to 160 of about 9,532 (171)

Pomalidomide

Reactions Weekly, 2022
  +4 more sources

Pomalidomide

Reactions Weekly, 2011
null Galustian, C., null Dalgleish, A.G.
openaire   +2 more sources

Pomalidomid

2013
Liebisch, Peter, Weisel, Katja, Wörmann, Bernhard, Goldschmidt, Hartmut, Deutsche Gesellschaft Für Hämatologie Und Medizinische Onkologie, Deutschland. Gemeinsamer Bundesausschuss, Einsele, Hermann, Naumann, Ralph   +7 more
openaire   +1 more source

Pomalidomide – Author Reply

Leukemia & Lymphoma, 2018
Ashleigh P. Scott, Peter Mollee
openaire   +5 more sources

Absorption, metabolism and excretion of [14C]pomalidomide in humans following oral administration

Cancer Chemotherapy and Pharmacology, 2012
Peter H Schafer, Gondi Kumar, Josephine Reyes   +2 more
exaly  

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Leukemia, 2012
Takumi Ito
exaly  

Randomized multicenter phase 2 study of pomalidomide, cyclophosphamide, and dexamethasone in relapsed refractory myeloma Free

Blood, 2016
Ajai Chari, Hui-Yi Lin, Thomas G Martin
exaly  

Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma

Annals of Oncology, 2016
Michel Attal, Herve Avet-Loiseau, Murielle Roussel   +2 more
exaly  

Phase 1 study of pomalidomide MTD, safety, and efficacy in patients with refractory multiple myeloma who have received lenalidomide and bortezomib

Blood, 2013
Jacob P Laubach, David Siegel, Paul G. Richardson   +2 more
exaly  

Pomalidomide Free

Blood, 2013
Martha Q Lacy
exaly